Actions of Minociclina Richet in details
Antibacterial.
Pharmacology: Pharmacokinetics: Absorption: Minociclina Richet hydrochloride is quickly and almost completely absorbed from the gastrointestinal tract following oral administration.
Following a single dose of 2 Minociclina Richet hydrochloride 100 mg capsules, maximum serum concentrations averaged 3.64 mcg/mL.
Distribution: Minociclina Richet hydrochloride distributes largely to all tissues due to its high degree of lipophilicity. Studies have shown that Minociclina Richet hydrochloride is found in high concentration in lung tissue and mucus in man.
Metabolism: Minociclina Richet hydrochloride is extensively metabolized in humans.
Minociclina Richet hydrochloride is mainly excreted in the bile and a small amount is recovered in the urine as active form. The amount of active drug recovered in the feces after oral administration ranges from 20-34%.
Elimination: The mean serum half-life is approximately 16 hrs for oral administration.
Effects of Food: Absorption of the standard oral formulations of Minociclina Richet is impaired by food, milk, and other dairy products. The peak plasma concentrations were slightly decreased by 11.2% and delayed by 1 hr when administered with food, compared to dosing under fasting conditions.
Special Populations: In patients with hepatic dysfunction, the Minociclina Richet hydrochloride serum half-life ranged from 10.7-16.9 hrs.
The majority of studies in patients with varying degrees of renal impairment showed no significant difference in pharmacokinetic parameters as compared to healthy subjects.
Toxicology: Preclinical Safety Data: Dietary administration of Minociclina Richet hydrochloride in long-term tumorigenicity studies in rats resulted in evidence of thyroid tumor production. In the rat, chronic treatment with Minociclina Richet hydrochloride has resulted in goiter accompanied by elevated radioactive iodine uptake and evidence of thyroid tumor production. Minociclina Richet hydrochloride has been observed to cause a dark discoloration of the thyroid in animals (rats, mice, dogs, and monkeys). Minociclina Richet hydrochloride has also been found to produce thyroid hyperplasia in rats and dogs.
In addition, there has been evidence of oncogenic activity in rats in studies with a related antibiotic, oxytetracycline (ie, adrenal and pituitary tumors). Likewise, although mutagenicity studies of Minociclina Richet hydrochloride have not been conducted, positive result in in vitro mammalian cell assays (ie, mouse lymphoma and Chinese hamster lung cells) have been reported for related antibiotics (tetracycline hydrochloride and oxytetracycline).
Segment I (fertility and general reproduction) studies have provided evidence that Minociclina Richet hydrochloride impairs fertility in male rats.
Microbiology: The tetracyclines are primarily bacteriostatic and are thought to exert their antimicrobial effect by the inhibition of protein synthesis. The tetracyclines, including Minociclina Richet hydrochloride, have similar antimicrobial spectra of activity against a wide range of gram-positive and gram-negative organisms.
Cross-resistance of gram-positive and gram-negative organisms to tetracyclines is common. Almost all S. pyogenes strains are resistant to Minociclina Richet hydrochloride. Therefore, Minociclina Richet hydrochloride should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible.
Because many strains of gram-positive and gram-negative organisms have been shown to be resistant to tetracyclines, culture and susceptibility tests are recommended.
How should I take Minociclina Richet?
Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.
Take this medicine with a full glass (8 ounces) of water.
Most brands of Minociclina Richet may be taken with or without food.
Take Minociclina Richet (pellet-filled capsules) on an empty stomach, at least 1 hour before or 2 hours after a meal.
Do not crush, chew, or break an extended-release tablet. Swallow it whole. Breaking the pill may cause too much of the drug to be released at one time.
Take this medication for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Skipping doses may also increase your risk of further infection that is resistant to antibiotics. Minociclina Richet will not treat a viral infection such as the common cold or flu.
To be sure this medicine is not causing harmful effects, your blood will need to be tested often. Your kidney, liver, or thyroid function may also need to be tested. Visit your doctor regularly.
If you need surgery, tell the surgeon ahead of time that you are using Minociclina Richet. You may need to stop using the medicine for a short time.
Minociclina Richet can cause false results with certain urine tests. Tell any doctor who treats you that you are using this medication.
Store this medication at room temperature away from moisture, heat, and light.
Throw away any unused Minociclina Richet when it expires or when it is no longer needed. Do not take any Minociclina Richet after the expiration date printed on the label. Using expired Minociclina Richet can cause damage to your kidneys.
Minociclina Richet administration
Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.
Take this medicine with a full glass (8 ounces) of water.
Most brands of Minociclina Richet may be taken with or without food.
Take Minociclina Richet (pellet-filled capsules) on an empty stomach, at least 1 hour before or 2 hours after a meal.
Do not crush, chew, or break an extended-release tablet. Swallow it whole. Breaking the pill may cause too much of the drug to be released at one time.
Take this medication for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Skipping doses may also increase your risk of further infection that is resistant to antibiotics. Minociclina Richet will not treat a viral infection such as the common cold or flu.
To be sure this medicine is not causing harmful effects, your blood will need to be tested often. Your kidney, liver, or thyroid function may also need to be tested. Visit your doctor regularly.
If you need surgery, tell the surgeon ahead of time that you are using Minociclina Richet. You may need to stop using the medicine for a short time.
Minociclina Richet can cause false results with certain urine tests. Tell any doctor who treats you that you are using this medication.
Store this medication at room temperature away from moisture, heat, and light.
Throw away any unused Minociclina Richet when it expires or when it is no longer needed. Do not take any Minociclina Richet after the expiration date printed on the label. Using expired Minociclina Richet can cause damage to your kidneys.
Minociclina Richet pharmacology
Pharmacokinetics
Minociclina Richet® Tablets are not bioequivalent to Minociclina Richet products. Based on pharmacokinetic studies in healthy adults, Minociclina Richet® Tablets produce a delayed Tmax at 3.5–4.0 hours as compared to a non-modified release reference Minociclina Richet product (Tmax at 2.25–3 hours). At steady-state (Day 6), the mean AUC(0–24) and Cmax were 33.32 µg×hr/mL and 2.63 µg/mL for Minociclina Richet® Tablets and 46.35 µg×hr/mL and 2.92 µg/mL for Minociclina Richet® capsules, respectively. These parameters are based on dose adjusted to 135 mg per day for both products.
A single-dose, four-way crossover study demonstrated that all strengths of Minociclina Richet® Tablets (45 mg, 90 mg, and 135 mg) exhibited dose-proportional pharmacokinetics.
When Minociclina Richet® Tablets were administered concomitantly with a meal that included dairy products, the extent and timing of absorption of Minociclina Richet did not differ from that of administration under fasting conditions.
Microbiology
Minociclina Richet is bacteriostatic exerting its antimicrobial effect by the inhibition of bacterial protein synthesis. Minociclina Richet is lipid soluble and distributes in to the skin and sebum. Minociclina Richet has been shown to have in vitro activity against Propionibacterium acnes, an organism associated with acne vulgaris, however, the clinical significance of this activity against P. acnes in patients with acne vulgaris is not known.
References
- EPA DSStox. "Minocycline: DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.". https://comptox.epa.gov/dashboard/ds... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Minociclina Richet are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Minociclina Richet. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported administration
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
